1978 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Gennaro Ciliberto is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 26 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

CytoMatrix for a reliable and simple characterization of lung cancer stem cells from malignant pleural effusions

Bruschini, S., di Martino, S., Pisanu, M. E., Fattore, L., De Vitis, C., Laquintana, V., Buglioni, S., Tabbì, E., Cerri, A., Visca, P., Alessandrini, G., Facciolo, F., Napoli, C., Trombetta, M., Santoro, A., Crescenzi, A., Ciliberto, G. & Mancini, R., Mar 1 2020, In : Journal of Cellular Physiology. 235, 3, p. 1877-1887 11 p.

Research output: Contribution to journalArticle

Open Access
  • A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study

    Gamucci, T., Pizzuti, L., Natoli, C., Mentuccia, L., Sperduti, I., Barba, M., Sergi, D., Iezzi, L., Maugeri-Sacca, M., Vaccaro, A., Magnolfi, E., Gelibter, A., Barchiesi, G., Magri, V., D'Onofrio, L., Cassano, A., Rossi, E., Botticelli, A., Moscetti, L., Omarini, C. & 29 others, Fabbri, M. A., Scinto, A. F., Corsi, D., Carbognin, L., Mazzotta, M., Bria, E., Foglietta, J., Samaritani, R., Garufi, C., Mariani, L., Barni, S., Mirabelli, R., Sarmiento, R., Graziano, V., Santini, D., Marchetti, P., Tonini, G., Di Lauro, L., Sanguineti, G., Paoletti, G., Tomao, S., De Maria, R., Veltri, E., Paris, I., Giotta, F., Latorre, A., Giordano, A., Ciliberto, G. & Vici, P., 2019, In : Cancer Biology and Therapy. 20, 2, p. 192-200 9 p.

    Research output: Contribution to journalArticle

    A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study

    Gamucci, T., Pizzuti, L., Natoli, C., Mentuccia, L., Sperduti, I., Barba, M., Sergi, D., Iezzi, L., Maugeri-Saccà, M., Vaccaro, A., Magnolfi, E., Gelibter, A., Barchiesi, G., Magri, V., D’Onofrio, L., Cassano, A., Rossi, E., Botticelli, A., Moscetti, L., Omarini, C. & 29 others, Fabbri, M. A., Scinto, A. F., Corsi, D., Carbognin, L., Mazzotta, M., Bria, E., Foglietta, J., Samaritani, R., Garufi, C., Mariani, L., Barni, S., Mirabelli, R., Sarmiento, R., Graziano, V., Santini, D., Marchetti, P., Tonini, G., Di Lauro, L., Sanguineti, G., Paoletti, G., Tomao, S., De Maria, R., Veltri, E., Paris, I., Giotta, F., Latorre, A., Giordano, A., Ciliberto, G. & Vici, P., Feb 1 2019, In : Cancer Biology and Therapy. 20, 2, p. 192-200 9 p.

    Research output: Contribution to journalArticle

  • B4GALT1 Is a New Candidate to Maintain the Stemness of Lung Cancer Stem Cells

    De Vitis, C., Corleone, G., Salvati, V., Ascenzi, F., Pallocca, M., De Nicola, F., Fanciulli, M., di Martino, S., Bruschini, S., Napoli, C., Ricci, A., Bassi, M., Venuta, F., Rendina, E. A., Ciliberto, G. & Mancini, R., 2019, In : Journal of Clinical Medicine. 8, 11

    Research output: Contribution to journalArticle

    Combinations of immuno-checkpoint inhibitors predictive biomarkers only marginally improve their individual accuracy

    Pallocca, M., Angeli, D., Palombo, F., Sperati, F., Milella, M., Goeman, F., De Nicola, F., Fanciulli, M., Nisticò, P., Quintarelli, C. & Ciliberto, G., 2019, In : Journal of Translational Medicine. 17, 1

    Research output: Contribution to journalArticle